Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
One study found that after 82 weeks of treatment with a GLP-1 receptor agonist (exenatide), people had better scores on a test that measures how their weight affects their quality of life, self-esteem, and work performance, compared to people treated with another diabetes medicine (insulin glargine)
This selectivity was demonstrated in a study by Raun et al
Browse all Peptides & GLP-1 education Frequently Asked Questions Is Zepbound the same as compounded tirzepatide
Li et al., 2021)
The SURMOUNT clinical trial program, which began enrolling patients in 2019, provided the pivotal evidence for Zepbound's approval
US$ 25.23
US$ 22.81
US$ 20.11
US$ 23.87
US$ 23.96
US$ 27.06
